Defective waste disposal: Does it induce autoantibodies in SLE?

Annals of the Rheumatic Diseases

Volumn 62, Issue 1, 2003, Pages 1-3

  Charles, Peter J ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL ARTICLE; HUMAN; LUPUS ERYTHEMATOSUS; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; WASTE DISPOSAL;

ANIMALS; APOPTOSIS; AUTOANTIBODIES; AUTOANTIGENS; DISEASE SUSCEPTIBILITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MICE; MODELS, ANIMAL; PHAGOCYTOSIS;

EID: 0037215428     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.1.1     Document Type: Short Survey

References (22)

1. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythaematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994;179:1317-30.
2. Rosen A, Casciola-Rosen LA. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death and Differentiation 1999;6:6-12.
3. Huggins ML, Todd I, Cavers MA, Pavuluri SR, Tighe PJ, Powell RJ. Antibodies from systemic lupus erythaematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis. Clin Exp Immunol 1999;118:322-8.
4. Griedinger EL, Casciola-Rosen L, Morris SM, Hoffman RW, Rosen A. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 2000;43:881-8.
5. Mevorach D, Zhpou JL, Song X, Elkon KB. Systemic exposure to irradiated apoptotic cells induces autoantibody induction. J Exp Med 1998;188387-92.
6. Navratil JS, Ahearn JM. Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus. Current Rheumatol Rep 2001;3:191-8.
7. van Nieuwenhuijze AEM, van Lopik T, Smeenk RJT, Aarden LA. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: Putative implications for systemic lupus erythematosus. Ann Rheum Dis 2003;62:10-14.
8. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase 1-deficient mice. Nat Genet 2000;25:177-81.
9. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennant GA, Bybee A, et al. Serum amyloid P component controls chromatin degredation and prevents antinuclear autoimmunity. Nat Med 1999;5:852-3.
10. Mitchell DA, Pickering MC, Warren J, Fossati-Jimack L, Cortes-Hernandez J, Cook M, et al. C 1q deficiency and autoimmunity: The effects of genetic background on disease expression. J Immunol 2002;168:2538-43.
11. Du Clos TW, Zlock LT, Hicks PS, Mold C. Decreased autoantibody levels and enhanced survival of (N7BxN7W) mice treated with C-reactive protein. Clin Immunol Immunopathol 1994;70:22-7.
12. Licht R, van Bruggen MC, Oppers-Walgreen B, Rijke TP, Berden JH. Plasma levels of nucleosome and nucleosome-autoantibody complexes in murine lupus: Effects of disease progression and lipopolysaccharide administration. Arthritis Rheum 2001;44:1320-30.
13. Davies KA, Robson MG, Peters AM, Norsworthy P, Nash JT, Walport MA. Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus. Arthritis Rheum 2002;46:1028-38.
14. Davies KA, Peters AM, Beynon HL, Walport MA. Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 1992;90:2075-83.
15. de la Fuente H, Richaud-Patin Y, Jakez-Ocampo J, Gonzalez-Amaro R, Liorente L. Inate immune mechanisms in the pathogenesis of systemic lupus erythematosus. Immunol Lett 2001;77:175-80.
16. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centres of patients with systemic lupus erythemotosus. Arthritis Rheum 200;46:191-201.
17. Amoura Z, Piette JC, Chabre H, Cacoub H, Cacoub P, Popo T, et al. B. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum 1997;40:2217-25.
18. Charles PJ, Smeenk RJT, Dejong J, Feldmann M, Maini RN. Antibodies to dsDNA induced in RA following treatment with a monoclonal antibody to TNF. Arthritis Rheum 2000;43:2883-900.
19. Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type 1a. Proc Natl Acad Sci USA 1999;96:4552-7.
20. Wang J, Zheng L, Lobitto A, Chan FK, Dale J, Sneller M, et al. Inherited human caspase 10 deficiency mutations underlie defective lymphocyte and dendritic cell apoptosis in outoimmune lymphoproliferative syndrome type II. Cell 1999;98:47-58.
21. Casciola-Rosen L, Andrade F, Ulanet D, Wang WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for the initiation of autoimmunnity. J Exp Med 199; 190:815-26.
22. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walpart MJ, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 2002:July 1 (e-pub ahead of print).